Patritumab deruxtecan
Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) composed of a fully human anti-HER3 IgG1 monoclonal antibody and a cytotixic topoisomerase I inhibitor. Patritumab deruxtecan shows anticancer activity.
| Trivial name | HER3-DXd |
| Catalog Number | D4004 |
| CAS# | 2227102-46-5 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/patritumab-deruxtecan.html |